Fish oils claimed to beat breast cancer drug for effectiveness

The omega-3 essential fatty acid known as docosahexaenoic acid (DHA) is more effective at reducing the size of breast cancer tumours than the chemotherapy drug cisplatin, and can also reduce that drug’s harmful side effects, reports a new study published in the journal Cell Division. However, readers should not jump up and down in excitement quite yet in our view: The research was done on mice not humans: The lead researcher A.M. El-Mowafy of Egypt’s Mansoura University claimed, “Our results suggest a new, fruitful drug regimen in the management of solid tumours based on combining cisplatin and possibly other chemotherapeutics with DHA. DHA elicited prominent chemo-preventative effects on its own, and appreciably augmented those of cisplatin as well. Furthermore, this study is the first to reveal that DHA can obliterate lethal cisplatin-induced nephrotoxicity (kidney damage and renal tissue injury).” In animals who received 125 milligrams per kilogram of DHA, tumour growth was 38 percent less than in animals who received a placebo. Animals receiving cisplatin had 55 percent less tumour growth, while those treated with 250 milligrams per kilogram of DHA had 79 percent less. The combination of DHA and cisplatin not only reduced tumour growth by 81 percent compared with a placebo, it also returned white blood cell counts to normal levels. The 250 milligram per kilogram dose of DHA was nearly as effective at restoring a normal white blood cell count as the DHA-cisplatin combination. It is up to you to make your own mind up. (Source: Natural News)



, , , , , , , , , , , ,